Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:BCEL

Atreca (BCEL) Stock Price, News & Analysis

Atreca logo

About Atreca Stock (NASDAQ:BCEL)

Advanced Chart

Key Stats

Today's Range
$0.09
$0.09
50-Day Range
$0.09
$0.09
52-Week Range
$0.05
$1.20
Volume
N/A
Average Volume
4.61 million shs
Market Capitalization
$3.57 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive BCEL Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Atreca and its competitors with MarketBeat's FREE daily newsletter.

BCEL Stock News Headlines

Bicycle Therapeutics Is Looking Increasingly Attractive
Forget Nvidia, This “Ghost Town” Company Holds the Key to the AI Boom
Cold War Discovery Could Unlock $100 Trillion in Wealth Jeff recently traveled to an American ghost town to investigate this crazy Cold War story… Because it could hold the key to the entire $100 trillion AI boom. It involves an American ghost town with just 30 people… And a new twist to the AI boom that could make a lot of people rich.
Atreca, Inc. (0C1.MU)
Atreca Inc. Cl A
Atreca Stock (NASDAQ:BCEL), Short Interest Report
See More Headlines

BCEL Stock Analysis - Frequently Asked Questions

Atreca, Inc. (NASDAQ:BCEL) announced its quarterly earnings data on Tuesday, November, 2nd. The company reported ($0.74) earnings per share (EPS) for the quarter, meeting analysts' consensus estimates of ($0.74).

Atreca (BCEL) raised $126 million in an initial public offering on Thursday, June 20th 2019. The company issued 7,400,000 shares at $16.00-$18.00 per share. Cowen, Evercore ISI and Stifel acted as the underwriters for the IPO and Canaccord Genuity and Brookline Capital Markets were co-managers.

Based on aggregate information from My MarketBeat watchlists, some other companies that Atreca investors own include Editas Medicine (EDIT), NVIDIA (NVDA), Micron Technology (MU), Alector (ALEC), Advanced Micro Devices (AMD), PayPal (PYPL) and Meta Platforms (META).

Company Calendar

Last Earnings
11/02/2021
Today
7/13/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:BCEL
CIK
1532346
Fax
N/A
Employees
130
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
($2.50)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$97.16 million
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
-157.90%
Return on Assets
-71.39%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
1.58
Quick Ratio
1.58

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$2.01 per share
Price / Book
0.04

Miscellaneous

Outstanding Shares
39,624,000
Free Float
35,146,000
Market Cap
$3.57 million
Optionable
Optionable
Beta
1.03
The 10 Best AI Stocks to Own in 2025 Cover

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report

This page (NASDAQ:BCEL) was last updated on 7/13/2025 by MarketBeat.com Staff
From Our Partners